Loading…

HAL fluorescence cystoscopy and TURB one year of Romanian experience

Hexaminolevulinate blue light cystoscopy (HAL-BLC) represents an increasingly acknowledged method in bladder cancer diagnostic. We aimed to evaluate the importance of this procedure in cases of non-invasive bladder tumors (NIBT), to compare it with standard white light cystoscopy (WLC), and to estab...

Full description

Saved in:
Bibliographic Details
Published in:Journal of medicine and life 2009-04, Vol.2 (2), p.185-190
Main Authors: Geavlete, B, Mulţescu, R, Georgescu, D, Jecu, M, Geavlete, P
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 190
container_issue 2
container_start_page 185
container_title Journal of medicine and life
container_volume 2
creator Geavlete, B
Mulţescu, R
Georgescu, D
Jecu, M
Geavlete, P
description Hexaminolevulinate blue light cystoscopy (HAL-BLC) represents an increasingly acknowledged method in bladder cancer diagnostic. We aimed to evaluate the importance of this procedure in cases of non-invasive bladder tumors (NIBT), to compare it with standard white light cystoscopy (WLC), and to establish the efficiency of blue light transurethral bladder resection (BL-TURB). Between December 2007 and December 2008, WLC and BLC were performed in 70 cases. WL-TURB was performed for all lesions visible in WL, and BL-TURB for those only detected in BL. Patients diagnosed with NIBT were followed-up after an average period of 5 months (between 18 and 22 weeks) by WLC and BLC. The control group included the same number of consecutive cases of NIBT, which underwent only WLC and WL-TURB, as well as the same follow-up protocol as the study group. WLC correctly identified 115 tumors, and BLC, 157 tumors. The detection rate was 68.8% for WLC, with a 9.4% rate of false-positive results, and 94% for BLC, with a 14.6% rate of false-positive results. The diagnostic accuracy in CIS lesions was 57.3% for WLC and 95% for BLC, while in pTa tumors; it was 68.8% for WLC and 94% for BLC. 62 cases of the study group diagnosed with NIBT emphasized a recurrence rate of 6.4% after 5 months. The control group described a recurrence rate of 24.2%. HAL fluorescence cystoscopy is a valuable diagnostic method for patients with NIBT, with considerably improved accuracy by comparison to WLC, and a significant impact upon the short-term recurrence rate.
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_733928930</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>733928930</sourcerecordid><originalsourceid>FETCH-LOGICAL-p125t-d9f37bf14715cab6041be5220890251578e471f655f69da7e1453f40bd92d9b13</originalsourceid><addsrcrecordid>eNo1TztrwzAY1NDShDR_oWjrZNDb0pimjxQMhZBANyPZn8DFtlzJhvrf16XJLTfcg7sbtKZaiIwy9rlC25S-yAIhlVL8Dq0YoURLrtfo-bArsG-nECFV0FeAqzmNIVVhmLHta3w6H59w6AHPYCMOHh9DZ_vG9hh-BojNX-Ye3XrbJtheeIPOry-n_SErPt7e97siGyiTY1Ybz3PnqciprKxTRFAHkjGiDWGSylzDInklpVemtjlQIbkXxNWG1cZRvkGP_71DDN8TpLHsmmV129oewpTKnHPDtOFkcT5cnJProC6H2HQ2zuX1OP8FWr1Skw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733928930</pqid></control><display><type>article</type><title>HAL fluorescence cystoscopy and TURB one year of Romanian experience</title><source>Open Access: PubMed Central</source><creator>Geavlete, B ; Mulţescu, R ; Georgescu, D ; Jecu, M ; Geavlete, P</creator><creatorcontrib>Geavlete, B ; Mulţescu, R ; Georgescu, D ; Jecu, M ; Geavlete, P</creatorcontrib><description>Hexaminolevulinate blue light cystoscopy (HAL-BLC) represents an increasingly acknowledged method in bladder cancer diagnostic. We aimed to evaluate the importance of this procedure in cases of non-invasive bladder tumors (NIBT), to compare it with standard white light cystoscopy (WLC), and to establish the efficiency of blue light transurethral bladder resection (BL-TURB). Between December 2007 and December 2008, WLC and BLC were performed in 70 cases. WL-TURB was performed for all lesions visible in WL, and BL-TURB for those only detected in BL. Patients diagnosed with NIBT were followed-up after an average period of 5 months (between 18 and 22 weeks) by WLC and BLC. The control group included the same number of consecutive cases of NIBT, which underwent only WLC and WL-TURB, as well as the same follow-up protocol as the study group. WLC correctly identified 115 tumors, and BLC, 157 tumors. The detection rate was 68.8% for WLC, with a 9.4% rate of false-positive results, and 94% for BLC, with a 14.6% rate of false-positive results. The diagnostic accuracy in CIS lesions was 57.3% for WLC and 95% for BLC, while in pTa tumors; it was 68.8% for WLC and 94% for BLC. 62 cases of the study group diagnosed with NIBT emphasized a recurrence rate of 6.4% after 5 months. The control group described a recurrence rate of 24.2%. HAL fluorescence cystoscopy is a valuable diagnostic method for patients with NIBT, with considerably improved accuracy by comparison to WLC, and a significant impact upon the short-term recurrence rate.</description><identifier>ISSN: 1844-122X</identifier><identifier>PMID: 20108538</identifier><language>eng</language><publisher>Romania</publisher><subject>Cystoscopy - methods ; False Positive Reactions ; Humans ; Microscopy, Fluorescence - methods ; Reproducibility of Results ; Romania ; Urinary Bladder Neoplasms - diagnosis ; Urinary Bladder Neoplasms - pathology ; Urinary Bladder Neoplasms - surgery ; Urologic Surgical Procedures - methods ; Urothelium - pathology ; Urothelium - surgery</subject><ispartof>Journal of medicine and life, 2009-04, Vol.2 (2), p.185-190</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20108538$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Geavlete, B</creatorcontrib><creatorcontrib>Mulţescu, R</creatorcontrib><creatorcontrib>Georgescu, D</creatorcontrib><creatorcontrib>Jecu, M</creatorcontrib><creatorcontrib>Geavlete, P</creatorcontrib><title>HAL fluorescence cystoscopy and TURB one year of Romanian experience</title><title>Journal of medicine and life</title><addtitle>J Med Life</addtitle><description>Hexaminolevulinate blue light cystoscopy (HAL-BLC) represents an increasingly acknowledged method in bladder cancer diagnostic. We aimed to evaluate the importance of this procedure in cases of non-invasive bladder tumors (NIBT), to compare it with standard white light cystoscopy (WLC), and to establish the efficiency of blue light transurethral bladder resection (BL-TURB). Between December 2007 and December 2008, WLC and BLC were performed in 70 cases. WL-TURB was performed for all lesions visible in WL, and BL-TURB for those only detected in BL. Patients diagnosed with NIBT were followed-up after an average period of 5 months (between 18 and 22 weeks) by WLC and BLC. The control group included the same number of consecutive cases of NIBT, which underwent only WLC and WL-TURB, as well as the same follow-up protocol as the study group. WLC correctly identified 115 tumors, and BLC, 157 tumors. The detection rate was 68.8% for WLC, with a 9.4% rate of false-positive results, and 94% for BLC, with a 14.6% rate of false-positive results. The diagnostic accuracy in CIS lesions was 57.3% for WLC and 95% for BLC, while in pTa tumors; it was 68.8% for WLC and 94% for BLC. 62 cases of the study group diagnosed with NIBT emphasized a recurrence rate of 6.4% after 5 months. The control group described a recurrence rate of 24.2%. HAL fluorescence cystoscopy is a valuable diagnostic method for patients with NIBT, with considerably improved accuracy by comparison to WLC, and a significant impact upon the short-term recurrence rate.</description><subject>Cystoscopy - methods</subject><subject>False Positive Reactions</subject><subject>Humans</subject><subject>Microscopy, Fluorescence - methods</subject><subject>Reproducibility of Results</subject><subject>Romania</subject><subject>Urinary Bladder Neoplasms - diagnosis</subject><subject>Urinary Bladder Neoplasms - pathology</subject><subject>Urinary Bladder Neoplasms - surgery</subject><subject>Urologic Surgical Procedures - methods</subject><subject>Urothelium - pathology</subject><subject>Urothelium - surgery</subject><issn>1844-122X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNo1TztrwzAY1NDShDR_oWjrZNDb0pimjxQMhZBANyPZn8DFtlzJhvrf16XJLTfcg7sbtKZaiIwy9rlC25S-yAIhlVL8Dq0YoURLrtfo-bArsG-nECFV0FeAqzmNIVVhmLHta3w6H59w6AHPYCMOHh9DZ_vG9hh-BojNX-Ye3XrbJtheeIPOry-n_SErPt7e97siGyiTY1Ybz3PnqciprKxTRFAHkjGiDWGSylzDInklpVemtjlQIbkXxNWG1cZRvkGP_71DDN8TpLHsmmV129oewpTKnHPDtOFkcT5cnJProC6H2HQ2zuX1OP8FWr1Skw</recordid><startdate>200904</startdate><enddate>200904</enddate><creator>Geavlete, B</creator><creator>Mulţescu, R</creator><creator>Georgescu, D</creator><creator>Jecu, M</creator><creator>Geavlete, P</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200904</creationdate><title>HAL fluorescence cystoscopy and TURB one year of Romanian experience</title><author>Geavlete, B ; Mulţescu, R ; Georgescu, D ; Jecu, M ; Geavlete, P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p125t-d9f37bf14715cab6041be5220890251578e471f655f69da7e1453f40bd92d9b13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Cystoscopy - methods</topic><topic>False Positive Reactions</topic><topic>Humans</topic><topic>Microscopy, Fluorescence - methods</topic><topic>Reproducibility of Results</topic><topic>Romania</topic><topic>Urinary Bladder Neoplasms - diagnosis</topic><topic>Urinary Bladder Neoplasms - pathology</topic><topic>Urinary Bladder Neoplasms - surgery</topic><topic>Urologic Surgical Procedures - methods</topic><topic>Urothelium - pathology</topic><topic>Urothelium - surgery</topic><toplevel>online_resources</toplevel><creatorcontrib>Geavlete, B</creatorcontrib><creatorcontrib>Mulţescu, R</creatorcontrib><creatorcontrib>Georgescu, D</creatorcontrib><creatorcontrib>Jecu, M</creatorcontrib><creatorcontrib>Geavlete, P</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicine and life</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Geavlete, B</au><au>Mulţescu, R</au><au>Georgescu, D</au><au>Jecu, M</au><au>Geavlete, P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>HAL fluorescence cystoscopy and TURB one year of Romanian experience</atitle><jtitle>Journal of medicine and life</jtitle><addtitle>J Med Life</addtitle><date>2009-04</date><risdate>2009</risdate><volume>2</volume><issue>2</issue><spage>185</spage><epage>190</epage><pages>185-190</pages><issn>1844-122X</issn><abstract>Hexaminolevulinate blue light cystoscopy (HAL-BLC) represents an increasingly acknowledged method in bladder cancer diagnostic. We aimed to evaluate the importance of this procedure in cases of non-invasive bladder tumors (NIBT), to compare it with standard white light cystoscopy (WLC), and to establish the efficiency of blue light transurethral bladder resection (BL-TURB). Between December 2007 and December 2008, WLC and BLC were performed in 70 cases. WL-TURB was performed for all lesions visible in WL, and BL-TURB for those only detected in BL. Patients diagnosed with NIBT were followed-up after an average period of 5 months (between 18 and 22 weeks) by WLC and BLC. The control group included the same number of consecutive cases of NIBT, which underwent only WLC and WL-TURB, as well as the same follow-up protocol as the study group. WLC correctly identified 115 tumors, and BLC, 157 tumors. The detection rate was 68.8% for WLC, with a 9.4% rate of false-positive results, and 94% for BLC, with a 14.6% rate of false-positive results. The diagnostic accuracy in CIS lesions was 57.3% for WLC and 95% for BLC, while in pTa tumors; it was 68.8% for WLC and 94% for BLC. 62 cases of the study group diagnosed with NIBT emphasized a recurrence rate of 6.4% after 5 months. The control group described a recurrence rate of 24.2%. HAL fluorescence cystoscopy is a valuable diagnostic method for patients with NIBT, with considerably improved accuracy by comparison to WLC, and a significant impact upon the short-term recurrence rate.</abstract><cop>Romania</cop><pmid>20108538</pmid><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1844-122X
ispartof Journal of medicine and life, 2009-04, Vol.2 (2), p.185-190
issn 1844-122X
language eng
recordid cdi_proquest_miscellaneous_733928930
source Open Access: PubMed Central
subjects Cystoscopy - methods
False Positive Reactions
Humans
Microscopy, Fluorescence - methods
Reproducibility of Results
Romania
Urinary Bladder Neoplasms - diagnosis
Urinary Bladder Neoplasms - pathology
Urinary Bladder Neoplasms - surgery
Urologic Surgical Procedures - methods
Urothelium - pathology
Urothelium - surgery
title HAL fluorescence cystoscopy and TURB one year of Romanian experience
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T04%3A31%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=HAL%20fluorescence%20cystoscopy%20and%20TURB%20one%20year%20of%20Romanian%20experience&rft.jtitle=Journal%20of%20medicine%20and%20life&rft.au=Geavlete,%20B&rft.date=2009-04&rft.volume=2&rft.issue=2&rft.spage=185&rft.epage=190&rft.pages=185-190&rft.issn=1844-122X&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E733928930%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p125t-d9f37bf14715cab6041be5220890251578e471f655f69da7e1453f40bd92d9b13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=733928930&rft_id=info:pmid/20108538&rfr_iscdi=true